- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03424109
Primary Palliative Care for Emergency Medicine (PRIM-ER)
March 19, 2024 updated by: NYU Langone Health
This proposal builds upon the evaluation of Primary Palliative Care Education, Training, and Technical Support for Emergency Medicine (PRIM-ER) implemented in 33 Emergency Departments (EDs).
This is a retrospective cohort study that seeks to measure the effect of PRIM-ER on older adults with serious illness on aspects of: 1) ED disposition to an acute setting; 2) healthcare utilization in the 6 months following the index ED visit; 3) survival following the index ED visit; and 4) determine site, provider, and patient-level characteristics that are associated with variation in impact of PRIM-ER across sites.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
57717
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
New York, New York, United States, 10016
- New York University School of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
66 years and older (Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Eligible patients will include ED patients 66 years or older with serious, life-limiting illness who visited any of our EDs during the implementation of PRIM-ER.
Description
Inclusion Criteria:
- Patients must demonstrate one-year mortality of at least 30 percent (score > 6) according to the Gagne Index, a validated instrument used to measure all cause one-year mortality in community-dwelling older adults, calculated based on their prior 12 months before the index ED visit of Medicare claims.
Exclusion Criteria:
- ED patients transferred from a nursing home on the index ED visit will be excluded since prediction of mortality and disposition of such patients differs from community-dwelling adults.
- Patients currently receiving hospice at the time of the index ED visit will also be excluded since they have already received services.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Retrospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Beneficiaries with a one-year mortality of at least 30%
The patient cohort will be extracted via the Centers for Medicare and Medicaid Services (CMS) Research Data Assistance Center (ResDAC) using a two-step process to maximize diversity, and minimize intentional or unintentional exclusions based on risk, age, health literacy, demographics, or expected adherence.
|
The analysis of the effect of PRIM-ER on ED disposition using a generalized linear binomial model with random site level effects.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Acute care admission
Time Frame: Index Visit
|
Will be measured on the index ED visit, and will be a dichotomous variable for an acute care admission (Yes/No).
|
Index Visit
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
ED revisits
Time Frame: 6 Months
|
Will be measured as the number of ED revisits in the six months following the index ED visit (Count).
|
6 Months
|
Inpatient days
Time Frame: 6 Months
|
Will be measured as the number of inpatient stays in the six months following the index ED visit (Count)
|
6 Months
|
Home health use
Time Frame: 6 Months
|
Will be measured as a dichotomous variable for any home health use in the six months following the index ED visit (Yes/No)
|
6 Months
|
Hospice use
Time Frame: 6 Months
|
Will be measured as a dichotomous variable for any hospice use in the six months following the index ED visit (Yes/No)
|
6 Months
|
Survival
Time Frame: 6 Months
|
Will be measured as a dichotomous variable for death in the six months following the index ED visit (Yes/No)
|
6 Months
|
Survival: Time-to-event
Time Frame: 6 Months
|
Will be measured as the number of days from index ED visit to death among those who died within six months following the index ED visit (Count of days)
|
6 Months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Keith S Goldfeld, DrPH, MS, MPA, NYU Langone Health
- Principal Investigator: Corita R Grudzen, MD, MSHS, FACEP, Memorial Sloan Kettering Cancer Center
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Chung FR, Turecamo S, Cuthel AM, Grudzen CR; PRIM-ER Investigators. Effectiveness and Reach of the Primary Palliative Care for Emergency Medicine (PRIM-ER) Pilot Study: a Qualitative Analysis. J Gen Intern Med. 2021 Feb;36(2):296-304. doi: 10.1007/s11606-020-06302-2. Epub 2020 Oct 27.
- Tan A, Durbin M, Chung FR, Rubin AL, Cuthel AM, McQuilkin JA, Modrek AS, Jamin C, Gavin N, Mann D, Swartz JL, Austrian JS, Testa PA, Hill JD, Grudzen CR; Group Authorship: Corita R. Grudzen on behalf of the PRIM-ER Clinical Informatics Advisory Board. Design and implementation of a clinical decision support tool for primary palliative Care for Emergency Medicine (PRIM-ER). BMC Med Inform Decis Mak. 2020 Jan 28;20(1):13. doi: 10.1186/s12911-020-1021-7.
- Grudzen CR, Brody AA, Chung FR, Cuthel AM, Mann D, McQuilkin JA, Rubin AL, Swartz J, Tan A, Goldfeld KS; PRIM-ER Investigators. Primary Palliative Care for Emergency Medicine (PRIM-ER): Protocol for a Pragmatic, Cluster-Randomised, Stepped Wedge Design to Test the Effectiveness of Primary Palliative Care Education, Training and Technical Support for Emergency Medicine. BMJ Open. 2019 Jul 27;9(7):e030099. doi: 10.1136/bmjopen-2019-030099.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 2019
Primary Completion (Actual)
June 1, 2023
Study Completion (Estimated)
June 30, 2024
Study Registration Dates
First Submitted
January 30, 2018
First Submitted That Met QC Criteria
February 5, 2018
First Posted (Actual)
February 6, 2018
Study Record Updates
Last Update Posted (Actual)
March 21, 2024
Last Update Submitted That Met QC Criteria
March 19, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 17-01819
- 5UH3AT009844 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Will share all policies, practices, materials, and tools to facilitate collaboration, reuse, and replication, including clinical workflows, design specifications for our clinical decision support and learning management system, code sets for extraction, and definition of data from Medicare administrative claims.
PI will comply with the ResDAC VRDC rules regarding the sharing and reporting of data in aggregate form only.
A final dataset will not be available for collaboration, reuse, and replication of the findings because of our decision to use the ResDAC VRDC.
IPD Sharing Time Frame
Immediately following publication.
No end date.
IPD Sharing Access Criteria
Investigators whose proposed use of the data has been approved by an independent review committee ("learned intermediary") identified for this purpose.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ANALYTIC_CODE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Emergencies
-
Betsi Cadwaladr University Health BoardRecruitingMedical EmergenciesUnited Kingdom
-
Universidad de AntioquiaCompleted
-
Second Affiliated Hospital, School of Medicine,...UnknownMedical EmergenciesChina
-
Central Hospital, Nancy, FranceCompleted
-
Technische Universität DresdenCompletedPerformance in Simulated Emergencies | Stress During Simulator Scenario | Behaviour of Physicians in Simulated EmergenciesGermany
-
Charite University, Berlin, GermanyZentralinstitut für die Kassenärztliche Versorgung in DeutschlandUnknownNon-urgent EmergenciesGermany
-
Peking University People's HospitalBeijing Emergency Medical Center; Beijing Red Cross Emergency CenterCompletedEmergencies [Disease/Finding]China
-
M.D. Anderson Cancer CenterRecruitingOncologic Complications and EmergenciesUnited States
-
Copenhagen Academy for Medical Education and SimulationCompletedCardiopulmonary Resuscitation | Education | Medical Emergencies
-
Mbarara University of Science and TechnologyUniversity of CalgaryCompletedMaternal, Pediatric Care EmergenciesUganda
Clinical Trials on healthcare service utilization in the six months following the ED visit
-
International Centre for Diarrhoeal Disease Research...RecruitingMaternal Health | Child Health | Vaccination | Family Planning ServicesBangladesh
-
Association Francaise pour la Recherche ThermaleUniversity Hospital, Grenoble; FloralisCompleted
-
Medical University of GrazCompleted
-
René Husted WorckBiosense Webster, Inc.Completed
-
Kirby InstituteCompleted
-
Association Francaise pour la Recherche ThermaleUniversity Hospital, Grenoble; FloralisCompletedFibromyalgia | Rheumatism, MuscularFrance
-
Memorial Sloan Kettering Cancer CenterWeill Medical College of Cornell University; McMaster UniversityCompleted
-
Memorial Sloan Kettering Cancer CenterCompletedHistory of CancerUnited States
-
Nantes University HospitalCompletedPatients Receiving Animal-derived Bioprosthetic Heart ValvesFrance, Canada, Italy, Spain
-
Jaeb Center for Health ResearchRecruitingCystic FibrosisUnited States